CSFZX | VGSCX | CSFZX / VGSCX | |
Total Expense Ratio | 0.84 | 1.99 | 42% |
Annual Report Gross Expense Ratio | 0.84 | 2.16 | 39% |
Fund Existence | 11 years | 17 years | - |
Gain YTD | 11.355 | 9.890 | 115% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.08B | 391M | 532% |
Annual Yield % from dividends | 2.80 | 1.33 | 210% |
Returns for 1 year | 1.08 | 1.11 | 98% |
Returns for 3 years | 33.29 | 31.57 | 105% |
Returns for 5 years | 30.56 | 28.18 | 108% |
Returns for 10 years | 48.82 | 44.44 | 110% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JAGLX | 75.17 | 0.46 | +0.62% |
Janus Henderson Global Life Sciences T | |||
SSRRX | 6.71 | 0.03 | +0.45% |
Touchstone Small Company R6 | |||
GMVRX | 16.40 | 0.04 | +0.24% |
Goldman Sachs Small/Mid Cap Equity R | |||
ABALX | 39.02 | 0.05 | +0.13% |
American Funds American Balanced A | |||
SGQIX | 46.28 | -0.03 | -0.06% |
DWS International Growth Inst |